MedTrace Logo

To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume

NCT04784299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2024-12-19

No results posted yet for this study

Summary

A Study to Evaluate the Performance and Safety of YVOIRE volume plus for Temporary Improvement of Mid-face Volume

Conditions

  • Midface Volume Deficit

Interventions

DEVICE

YVOIRE volume plus

Hyaluronic acid dermal filler

DEVICE

Restylane Lyft with Lidocaine

Hyaluronic acid dermal filler

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Principal Investigators

  • Investigator · LG Chem Investigational site 01

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2022-04-11
Completion
2022-10-26

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04784299 on ClinicalTrials.gov